These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14722707)

  • 61. From ecstasy to MDMA: Recreational drug use, symbolic boundaries, and drug trends.
    Edland-Gryt M; Sandberg S; Pedersen W
    Int J Drug Policy; 2017 Dec; 50():1-8. PubMed ID: 28869878
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of neuronal nitric oxide synthase suppresses the maintenance but not the induction of psychomotor sensitization to MDMA ('Ecstasy') and p-chloroamphetamine in mice.
    Anderson KL; Itzhak Y
    Nitric Oxide; 2003 Aug; 9(1):24-32. PubMed ID: 14559429
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users.
    Croft RJ; Klugman A; Baldeweg T; Gruzelier JH
    Am J Psychiatry; 2001 Oct; 158(10):1687-92. PubMed ID: 11579003
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Measurement of startle response, prepulse inhibition, and habituation.
    Geyer MA; Swerdlow NR
    Curr Protoc Neurosci; 2001 May; Chapter 8():Unit 8.7. PubMed ID: 18428548
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impaired prepulse inhibition and habituation of acoustic startle response in Japanese patients with schizophrenia.
    Takahashi H; Iwase M; Ishii R; Ohi K; Fukumoto M; Azechi M; Ikezawa K; Kurimoto R; Canuet L; Nakahachi T; Iike N; Tagami S; Morihara T; Okochi M; Tanaka T; Kazui H; Yoshida T; Tanimukai H; Yasuda Y; Kudo T; Hashimoto R; Takeda M
    Neurosci Res; 2008 Nov; 62(3):187-94. PubMed ID: 18789980
    [TBL] [Abstract][Full Text] [Related]  

  • 66. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
    Kish SJ
    Pharmacol Biochem Behav; 2002 Apr; 71(4):845-55. PubMed ID: 11888575
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Repeated testing of prepulse inhibition and habituation of the startle reflex: a study in healthy human controls.
    Abel K; Waikar M; Pedro B; Hemsley D; Geyer M
    J Psychopharmacol; 1998; 12(4):330-7. PubMed ID: 10065906
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Disruption of prepulse inhibition by 3,4-methylenedioxymethamphetamine (MDMA): comparison between male and female wild-type and 5-HT(1A) receptor knockout mice.
    van den Buuse M; Becker T; Kwek P; Martin S; Ruimschotel E; Risbrough V
    Int J Neuropsychopharmacol; 2011 Jul; 14(6):856-61. PubMed ID: 21329554
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
    Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Proton magnetic resonance spectroscopy in ecstasy (MDMA) users.
    Daumann J; Fischermann T; Pilatus U; Thron A; Moeller-Hartmann W; Gouzoulis-Mayfrank E
    Neurosci Lett; 2004 May; 362(2):113-6. PubMed ID: 15193766
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report.
    Reneman L; Majoie CB; Schmand B; van den Brink W; den Heeten GJ
    Biol Psychiatry; 2001 Oct; 50(7):550-4. PubMed ID: 11600108
    [TBL] [Abstract][Full Text] [Related]  

  • 76. p-Chloroamphetamine (PCA): acute and chronic effects on habituation and sensitization of the acoustic startle response in rats.
    Davis M; Sheard MH
    Eur J Pharmacol; 1976 Feb; 35(2):261-73. PubMed ID: 129331
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Are ecstasy induced serotonergic alterations overestimated for the majority of users?
    Szigeti B; Winstock AR; Erritzoe D; Maier LJ
    J Psychopharmacol; 2018 Jul; 32(7):741-748. PubMed ID: 29733742
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.
    Reneman L; Booij J; Schmand B; van den Brink W; Gunning B
    Psychopharmacology (Berl); 2000 Feb; 148(3):322-4. PubMed ID: 10755746
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Memory impairment in abstinent MDMA ("Ecstasy") users: a longitudinal investigation.
    Zakzanis KK; Young DA
    Neurology; 2001 Apr; 56(7):966-9. PubMed ID: 11294938
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent 'Ecstasy' users.
    Roberts CA; Quednow BB; Montgomery C; Parrott AC
    Neurosci Biobehav Rev; 2018 Jan; 84():470-482. PubMed ID: 28801175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.